Viewing Study NCT00748709

Bugs

Ignite Creation Date: 2025-12-18 @ 4:14 AM

Ignite Modification Date: 2025-12-23 @ 6:58 PM

Study NCT ID: NCT00748709

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module